TransMedics Operating Cycle from 2010 to 2026

TMDX Stock  USD 135.30  2.79  2.02%   
TransMedics Operating Cycle yearly trend continues to be fairly stable with very little volatility. Operating Cycle will likely drop to 191.70 in 2026. During the period from 2010 to 2026, TransMedics Operating Cycle regression line of annual values had r-squared of  0.41 and arithmetic mean of  450.91. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
201.79
Current Value
191.7
Quarterly Volatility
149.1700399
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check TransMedics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TransMedics' main balance sheet or income statement drivers, such as Interest Expense of 17.4 M, Selling General Administrative of 203.6 M or Operating Income of 45.3 M, as well as many indicators such as Price To Sales Ratio of 5.13, Dividend Yield of 0.0 or PTB Ratio of 8.56. TransMedics financial statements analysis is a perfect complement when working with TransMedics Valuation or Volatility modules.
  
Build AI portfolio with TransMedics Stock
Check out the analysis of TransMedics Correlation against competitors.

Latest TransMedics' Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of TransMedics Group over the last few years. It is TransMedics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TransMedics' overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

TransMedics Operating Cycle Regression Statistics

Arithmetic Mean450.91
Geometric Mean419.80
Coefficient Of Variation33.08
Mean Deviation121.23
Median505.88
Standard Deviation149.17
Sample Variance22,252
Range492
R-Value(0.64)
Mean Square Error14,079
R-Squared0.41
Significance0.01
Slope(18.84)
Total Sum of Squares356,027

TransMedics Operating Cycle History

2026 191.7
2025 201.79
2024 175.47
2023 280.5
2022 374.65
2021 667.37
2020 581.49

About TransMedics Financial Statements

TransMedics investors use historical fundamental indicators, such as TransMedics' Operating Cycle, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in TransMedics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle 201.79  191.70 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.